Business Description
Guangzhou Kingmed Diagnostics Group Co Ltd
ISIN : CNE100002VW1
Share Class Description:
SHSE:603882: Class ACompare
Compare
Traded in other countries / regions
603882.China IPO Date
2017-09-08Description
Guangzhou Kingmed Diagnostics Group Co Ltd is a medical laboratory company. It is engaged in third-party medical testing and pathological diagnosis business. Further, it is also involved in clinical trials, food and hygiene testing, and scientific research service. Geographically, the business activities are carried out through China.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.21 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | 0.3 | |||||
| Interest Coverage | 90.91 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.24 | |||||
| Beneish M-Score | -2.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 42.2 | |||||
| 3-Year EBITDA Growth Rate | 68.6 | |||||
| 3-Year EPS without NRI Growth Rate | 88.5 | |||||
| 3-Year FCF Growth Rate | 41 | |||||
| 3-Year Book Growth Rate | 54.9 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.8 | |||||
| 9-Day RSI | 52.62 | |||||
| 14-Day RSI | 50.91 | |||||
| 6-1 Month Momentum % | -30.81 | |||||
| 12-1 Month Momentum % | -1.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.61 | |||||
| Quick Ratio | 2.53 | |||||
| Cash Ratio | 0.59 | |||||
| Days Inventory | 18.36 | |||||
| Days Sales Outstanding | 219.39 | |||||
| Days Payable | 159.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.85 | |||||
| Dividend Payout Ratio | 0.6 | |||||
| 3-Year Dividend Growth Rate | 128 | |||||
| Forward Dividend Yield % | 2.85 | |||||
| 5-Year Yield-on-Cost % | 2.85 | |||||
| 3-Year Average Share Buyback Ratio | -0.7 | |||||
| Shareholder Yield % | 2.56 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.37 | |||||
| Operating Margin % | 18.25 | |||||
| Net Margin % | 12.16 | |||||
| ROE % | 16.63 | |||||
| ROA % | 10.38 | |||||
| ROIC % | 27.51 | |||||
| ROC (Joel Greenblatt) % | 30.39 | |||||
| ROCE % | 17.87 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.27 | |||||
| PE Ratio without NRI | 21.27 | |||||
| Shiller PE Ratio | 30.23 | |||||
| Price-to-Owner-Earnings | 34.75 | |||||
| PEG Ratio | 0.37 | |||||
| PS Ratio | 2.58 | |||||
| PB Ratio | 3.6 | |||||
| Price-to-Tangible-Book | 3.66 | |||||
| Price-to-Free-Cash-Flow | 40.66 | |||||
| Price-to-Operating-Cash-Flow | 20.44 | |||||
| EV-to-EBIT | 16.86 | |||||
| EV-to-EBITDA | 16.86 | |||||
| EV-to-Revenue | 2.38 | |||||
| EV-to-FCF | 37.91 | |||||
| Price-to-Projected-FCF | 1.85 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.84 | |||||
| Price-to-Graham-Number | 1.85 | |||||
| Price-to-Net-Current-Asset-Value | 6.11 | |||||
| Earnings Yield (Greenblatt) % | 5.94 | |||||
| Forward Rate of Return (Yacktman) % | 22.55 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guangzhou Kingmed Diagnostics Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 11,472.118 | ||
| EPS (TTM) (Â¥) | 2.98 | ||
| Beta | 0.73 | ||
| Volatility % | 40.68 | ||
| 14-Day RSI | 50.91 | ||
| 14-Day ATR (Â¥) | 1.969084 | ||
| 20-Day SMA (Â¥) | 60.4795 | ||
| 12-1 Month Momentum % | -1.5 | ||
| 52-Week Range (Â¥) | 55.78 - 92.91 | ||
| Shares Outstanding (Mil) | 467.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guangzhou Kingmed Diagnostics Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guangzhou Kingmed Diagnostics Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guangzhou Kingmed Diagnostics Group Co Ltd Frequently Asked Questions
What is Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882)'s stock price today?
The current price of SHSE:603882 is ¥62.36. The 52 week high of SHSE:603882 is ¥92.91 and 52 week low is ¥55.78.
When is next earnings date of Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882)?
The next earnings date of Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882) is .
Does Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882) pay dividends? If so, how much?
The Dividend Yield %  of Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882) is 2.85% (As of Today), Highest Dividend Payout Ratio of Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882) was 0.6. The lowest was 0.04. And the median was 0.12. The  Forward Dividend Yield % of Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882) is 2.85%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers